SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

New advisory client, Vertequip

9 Mar 2015 07:00

RNS Number : 7807G
Frontier IP Group plc
09 March 2015
 



 

 

AIM: FIPP

Frontier IP Group plc

("Frontier IP" or "the Company")

 

New Advisory Client - Vertequip

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has been engaged to provide advisory and business development services to VERTEQUIP - Equipamentos e trabalhos verticais, LDA ("Vertequip").

Vertequip, a Portuguese company, was formed to develop and exploit a new technology, STEP (http://site.vertequip.com/products), which allows the service and maintenance of high vertical structures to be performed in a safer, faster and more cost-effective way. Vertequip is targeting the renewable energy, construction, offshore oil & gas and relevant industrial markets. Current customers include utilities and energy companies, who respectively use Vertequip solutions in wind turbines and dams, and for the maintenance of offshore oil rigs.

Frontier IP will assist Vertequip in further exploiting the commercial potential of its technology and to accelerate the expansion of its sales into new and existing markets.

Neil Crabb, Chief Executive of Frontier IP, said,

"This collaboration with Vertequip represents an exciting opportunity for Frontier IP in the energy market. Our strategy to focus on energy as one of our key sectors is progressing well, as we expand our resource and build connections to a network of market players such as EDP and Iberdrola, two major utilities. We look forward to working with Vertequip to maximise the potential of its innovative technology and product range."

Pedro Goncalves, Chief Operating Officer of Vertequip, said,

"We are delighted to enter into this agreement and get the support of Frontier IP on the commercialisation of our innovative products."

 

Enquiries

 

Frontier IP Group Plc

0131 240 1251

 

Neil Crabb, Chief Executive

 

Company website: www.frontierip.co.uk

 

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

020 7894 7000

 

Mark Percy / Catherine Leftley, Corporate Finance

 

David Banks, Corporate Broking

 

 

Peterhouse Corporate Finance Limited (Joint Broker)

020 7469 0935

 

Lucy Williams

 

 

KTZ Communications

020 3178 6378

 

Katie Tzouliadis / Deborah Walter

 

 

Notes to Editor:

 

Frontier IP Group plc

Frontier IP specialises in assisting universities, research institutions and companies in the commercialisation and exploitation of their Intellectual Property.

 www.frontierip.co.uk.

 

Vertequip - Equipamentos e trabalhos verticais, LDA

Vertequip specialises in the production of service and maintenance equipment for high vertical structures, including oil rigs, wind turbines, mines and construction sites. Its principal product, STEP, is designed to increase safety and enhance productivity when working at considerable heights.

 

Vertiquip is based in Portugal, with distributors selling its products across Europe, Africa, the Middle East and South America.

http://site.vertequip.com/products

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAKMGGFMVKGKZM
Date   Source Headline
26th May 20267:00 amRNS-RPortfolio news: Dekiln strategic partnership
5th May 20267:00 amRNSAppointment of Chief Financial Officer
16th Apr 20264:07 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSPortfolio News: 2D Photonics subsidiary grant
13th Apr 20262:35 pmRNSHolding(s) in Company
10th Apr 202610:30 amRNSUpdate re Investee Company
8th Apr 20267:00 amRNS-RPortfolio news – Fieldwork Robotics £3M fundraise
31st Mar 20265:18 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSUnaudited Half Year Results
23rd Mar 20267:00 amRNS-RAlusid reaches milestone in European roll out
28th Jan 20264:28 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RPortfolio news - Strong results for TVG vaccine
12th Jan 202610:30 amRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 202512:30 pmRNSResult of AGM
31st Dec 202512:30 pmRNSResult of AGM
29th Dec 20252:37 pmRNSHolding(s) in Company
29th Dec 20252:37 pmRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20252:17 pmRNSDirectors' Shareholdings
23rd Dec 20252:17 pmRNSDirectors’ Shareholdings
22nd Dec 20253:48 pmRNSResult of Retail Offer
22nd Dec 20253:48 pmRNSResult of Retail Offer
18th Dec 20259:15 amRNS-RDekiln benefits from £3 million funding
17th Dec 202511:54 amRNSResult of Placing and Subscription
17th Dec 20257:01 amRNSRetail Offer
17th Dec 20257:00 amRNSProposed Placing and Subscription to raise £870k
15th Dec 20257:00 amRNS-RPortfolio news- Alusid £500k pre-IPO funding round
10th Dec 20254:56 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSPosting of Annual Report & Notice of AGM
8th Dec 20257:00 amRNSFinal results for the year ended 30 June 2025
2nd Dec 20257:00 amRNS-RAlusid signs Swedish distribution agreement
6th Nov 20257:00 amRNSBord Change
3rd Nov 20257:00 amRNS-RTVG demonstrates success in animal trials
20th Oct 20257:00 amRNS-RAmprologix raises £740,000 in Pre-Series A round
25th Sep 20257:00 amRNSBoard Changes
24th Sep 20255:12 pmRNSHolding(s) in Company
13th Jun 20257:00 amRNSStrategic partnership for Cambridge innovation hub
10th Jun 20257:00 amRNS-RAlusid signs international distribution agreement
6th May 20257:00 amRNS-RTVG's vaccine candidate enters animal trials
16th Apr 20257:00 amRNS-RSyva signs option to license agreement with TVG
2nd Apr 20254:47 pmRNSDirector/PDMR Shareholding
31st Mar 20251:02 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSUnaudited Half Year Results
24th Mar 20257:00 amRNSCamGraphIC secures €25 million in Series A funding
18th Mar 20257:00 amRNS-RPulsiv wins PSMA’s Global Energy Efficiency Award
25th Feb 20257:00 amRNS-RGraphEnergyTech collaboration & Innovate UK grant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.